BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients

AIM: A prospective dose escalation trial was developed to evaluate the maximum tolerated dose of stereotactic body radiotherapy (SABRT) to primary breast cancer in stage IV disease. The aim of the present report was to describe safety and outcome of the first dose level cohort of patients. MATERIAL...

Descripción completa

Detalles Bibliográficos
Autores principales: Ippolito, Edy, Silipigni, Sonia, Pantano, Francesco, Matteucci, Paolo, Carrafiello, Sofia, Marrocco, Maristella, Alaimo, Rita, Palumbo, Vincenzo, Fiore, Michele, Orsaria, Paolo, D’Angelillo, Rolando Maria, Altomare, Vittorio, Tonini, Giuseppe, Ramella, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064004/
https://www.ncbi.nlm.nih.gov/pubmed/37007063
http://dx.doi.org/10.3389/fonc.2023.1062355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064004/
https://www.ncbi.nlm.nih.gov/pubmed/37007063
http://dx.doi.org/10.3389/fonc.2023.1062355

Ejemplares similares